Substance
UPADACITINIB
Global reference: every product and company linked to this substance.
- cas: 1310726-60-3
- ncit: C152802
- pubchem_cid: 58557659
- rxnorm: 2196092
- unii: 4RA0KN46E0
ABBV-599 COMPONENT UPADACITINIB · ABT-494 · upadacitinib [INN] · UPADACITINIB [USAN] · Upadacitinib [WHO-DD]
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| ABBVIE INC. COMMON STOCK | RINVOQ | Q2 2026 | $2.5B |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (2)
- RINVOQ · ABBVIE INC. COMMON STOCK
- RINVOQ LQ · ABBVIE INC. COMMON STOCK